Page last updated: 2024-10-17

n(g),n(g')-dimethyl-l-arginine and Purpura, Thrombotic Thrombocytopenic

n(g),n(g')-dimethyl-l-arginine has been researched along with Purpura, Thrombotic Thrombocytopenic in 1 studies

N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine

Purpura, Thrombotic Thrombocytopenic: An acquired, congenital, or familial disorder caused by PLATELET AGGREGATION with THROMBOSIS in terminal arterioles and capillaries. Clinical features include THROMBOCYTOPENIA; HEMOLYTIC ANEMIA; AZOTEMIA; FEVER; and thrombotic microangiopathy. The classical form also includes neurological symptoms and end-organ damage, such as RENAL FAILURE. Mutations in the ADAMTS13 PROTEIN gene have been identified in familial cases.

Research Excerpts

ExcerptRelevanceReference
"Eleven patients with thrombotic thrombocytopenic purpura (TTP) or haemolytic uremic syndrome (HUS) were investigated with respect to plasma concentrations of L-arginine, a substrate for nitric oxide (NO) and asymmetrical dimethyl arginine (ADMA), during active disease and after recovery."1.30The arginine-nitric oxide pathway in thrombotic microangiopathy. ( Herlitz, H; Petersson, A; Sigström, L; Wennmalm, A; Westberg, G, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Herlitz, H1
Petersson, A1
Sigström, L1
Wennmalm, A1
Westberg, G1

Other Studies

1 other study available for n(g),n(g')-dimethyl-l-arginine and Purpura, Thrombotic Thrombocytopenic

ArticleYear
The arginine-nitric oxide pathway in thrombotic microangiopathy.
    Scandinavian journal of urology and nephrology, 1997, Volume: 31, Issue:5

    Topics: Adult; Aged; Arginine; Child, Preschool; Enzyme Inhibitors; Hemolytic-Uremic Syndrome; Humans; Middl

1997